Feature | September 03, 2021 | By Dave Fornell, Editor

Most Popular Cardiology Technology Content in August 2021

COVID in cardiology was again a key driver of content pageviews on DAIC in August 2021. Also, a key new technology that cardiologists had a lot of interest in was the release of 3D/4D intra-cardiac echocardiography (ICE) to better guide EP and structural heart procedures without the need for transesophageal echo and its associated need for deep anesthesia. 

COVID in cardiology was again a key driver of content pageviews on DAIC in August 2021. Also, a key new technology that cardiologists had a lot of interest in was the release of 3D/4D intra-cardiac echocardiography (ICE) to better guide EP and structural heart procedures without the need for transesophageal echo and its associated need for deep anesthesia. This was the topic of two articles from Northwestern Medicine and Mayo Clinic in the top content this month.


September 3, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of August 2021. This is based on the website’s 201,568 pageviews for the month.

Interest in COVID-19 is again rising amid the rapid rise in delta variant cases this past month. This not only includes a few articles in the top 10, but numerous archive articles on COVID from several months ago resurfaced among some of the top accessed DAIC content, accounting for more than 36,000 pageviews. The top 5 archive COVID articles are listed in a separate section below.

1. First-in-Human Experience With Novel 4D ICE Catheter For Catheter Ablation and LAA Closure Procedure

2. FDA Clears Abbott Amplatzer Amulet LAA Occluder to Reduce Stroke in People With Atrial Fibrillation

3. Large Study Confirms Statins Reduce COVID-19 Severity

4. Human ECG Monitoring Outperforms AI Dependent Remote Cardiac Monitoring

5. Overview of Myocarditis Cases Caused by the COVID-19 Vaccine

6. Heart Rhythm Society 2021 Late-Breaking Clinical Trials in Electrophysiology

7. COVID-19 Long-term Impacts Will Likely Include Higher Rates of Heart Disease

8. Pulsed Field Cryoablation Eliminated AF in 85% After Single Ablation Procedure

9. Mayo Clinic First to Use Next Generation 4D ICE System to Guide Structural Heart Procedures

10. St. Jude Medical Pays $27 Million for Allegedly Selling Defective Heart Devices

11. WEBINAR: Utilization of AI for Echocardiography Analysis and Outcome Prediction

12. FDA Adds Myocarditis Warning to COVID mRNA Vaccine Clinician Fact Sheets

13. COVID-19 Changes Properties Blood Cells

14. VIDEO: EP Trends and New Technology From Biosense Webster at HRS 2021

15. HIMSS 2021 Showed What to Expect From In-person Healthcare Conferences During the COVID Pandemic 

 

Top 6 Most Read COVID-19 Archive Content This Past Month:

1. Kawasaki-like Inflammatory Disease Affects Children With COVID-19

2. Addressing Atrial Fibrillation in the World of COVID-19

3. Overview of Myocarditis Cases Caused by the COVID-19 Vaccine

4. VIDEO: ECMO Hemodynamic Support Effective in Sickest COVID-19 Patients 

5. The Long-term Cardiovascular Impact of COVID-19

6. COVID-19 Therapy Drug Azithromycin May Increase Risk for Cardiac Events


Related Content

News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — A programming algorithm, being tested by HonorHealth Research Institute for those patients with new or ...

Home June 20, 2024
Home
Subscribe Now